The open index of psychedelic research

859. From Neurons to Behavior: Preclinical Insights into LSD’s Anxiolytic Mechanisms

575. A scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression

From depression to bone health: examining the skeletal effects of classical and rapid-acting antidepressants.

Louka P, Pitsillides AA, Koumas M +3

429. Association between subjective experiences and symptom improvement following psilocybin therapy in Japanese patients with treatment-resistant depression: an open-label study

263. Feasibility of psilocybin treatment in Japanese patients with treatment-resistant depression: an open-label study

507. Ketamine use disorder following intranasal esketamine for treatment-resistant depression: a case report and literature review

401. Prophylactic effects of LSD on inflammatory rodent model of depression

722. Predictors of therapeutic response to LSD in anxiety: short- and long-term outcomes

469. The serotonin 5-HT2A agonist psilocybin in the treatment of neuropathic pain

Effect of esketamine on postoperative pulmonary complications after radical surgery for lung cancer: A randomized double-blind controlled trial.

Huang J, Wang J, Gu X +2

Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions.

Ahmed M, Cabrera P, Doherty T +4

Psychopharmacology at an Inflection Point: From Syndromes to Stratified Mechanisms, Circuit-Based Treatments, and Precision Psychiatry.

Macaluso M

Efficacy of Esketamine as an Adjuvant for Fascia Iliaca Compartment Block on Postoperative Analgesia in Elderly Patients Undergoing Total Hip Arthroplasty.

Jia X, Zhang L, Zhou M

374. Intranasal esketamine in treatment-resistant bipolar depression maintained on long-acting aripiprazole

The Effects of Different Doses of Intravenous Esketamine on Postoperative Sleep and Chronic Pain in Patients Undergoing Thoracoscopic Lung Resection Surgery: A Randomized Controlled Trial

Li Y, Wang Y, Jin L +3

354. Effects of psilocybin treatment on cognitive function in Japanese patients with treatment-resistant depression: an open-label study

706. Neurobiology of MDMA and mechanisms in trauma recovery

701. Efficacy and safety of COMP360 psilocybin therapy in anorexia nervosa: a proof-of-concept study

717. Clinical trials, ethical dimensions, and the pathway of MDMA-assisted therapy in PTSD

669. Imaging reward circuitry to guide precision ketamine treatment in treatment-resistant depression

Ketamine Plus Midazolam versus Fentanyl Plus Midazolam for Sedation and Analgesia during Image-guided Procedures in Interventional Radiology: Randomized Clinical Trial.

Deipolyi AR, Bommineni M, Ahmad A +6

[Intravenous ketamine in suicidal crisis : indications and patient referral].

Nasserdine R, Xhymshiti L, Paporé AC +3

301. Multimodal MRI signatures predict ketamine antidepressant response in treatment-resistant depression: a machine-learning analysis of independent clinical trials

286. Restoration by ketamine metabolites of cognitive and affective prosocial behaviors in a mouse model of depression